BiotechTube
Sareum

Sareum

Cambridge, United Kingdom· Est.

Developing next generation kinase inhibitors for autoimmune disease & cancer.*Molecular structure of TYK2 kinase (blue) and a prototype inhibitor (gold) About us > https://sareum.com/wp-content/uploads/2023/03/3NYX_camera-spin-2.mp4 SCROLL DOWN Welcome to Sareum.Sareum is a clinical-stage small molecule company actively involved in developing next-generation kinase inhibitors to treat autoimmune diseases and cancer.We recognise the crucial role of the TYK/JAK

sareum.com

Private Company

Total funding raised: $16.2M

About

Developing next generation kinase inhibitors for autoimmune disease & cancer.*Molecular structure of TYK2 kinase (blue) and a prototype inhibitor (gold) About us > https://sareum.com/wp-content/uploads/2023/03/3NYX_camera-spin-2.mp4 SCROLL DOWN Welcome to Sareum.Sareum is a clinical-stage small molecule company actively involved in developing next-generation kinase inhibitors to treat autoimmune diseases and cancer.We recognise the crucial role of the TYK/JAK

Small Molecules

Funding History

2
Total raised:$16.2M
Grant$1.2M
Series A$15M
More companies in Small Molecule Drugs →More companies in United Kingdom →